To cite this paper use one of the standards below:
Malignant melanoma is the most aggressive form of skin cancer, and its high metastatic potential and frequent development of treatment resistance highlight the need for multimodal therapeutic strategies. This study investigated the in vitro effects of TMPyP-mediated photodynamic therapy (PDT) combined with radiotherapy (RT) by assessing selectivity toward non-malignant cells, clonogenic survival, and reactive oxygen species (ROS) production. Human melanoma cell lines SK-MEL-28 (BRAF-mutated, highly proliferative phenotype) and SK-MEL-147 (NRAS-mutated, more invasive phenotype), along with non-malignant fibroblasts (FN1), were used. Sublethal TMPyP concentrations (IC20) were determined, yielding 0.35 µM for SK-MEL-147 and 0.91 µM for SK-MEL-28 and FN1, and 2 Gy was selected for gamma irradiation. Cells were divided into Control, PDT, RT, PDT+RT, and RT+PDT groups. PDT was performed with red light irradiation (660 ± 20 nm, 50 J/cm², 78.43 mW/cm²). Individual treatments reduced clonogenic survival, with PDT producing cell line-dependent effects (35% survival in SK-MEL-28 and 43% in SK-MEL-147), whereas RT produced a uniform response (51%). The PDT+RT sequence sharply reduced viability to minimal survival levels (4% in SK-MEL-28 and 8% in SK-MEL-147), comparable to the reverse RT+PDT sequence (6% and 11%, respectively), while preserving FN1 viability. ROS analysis revealed cell line-dependent differences in the early oxidative response, suggesting distinct initial mechanisms of stress adaptation. Although early ROS changes did not directly correlate with clonogenic outcomes after 14 days, both combined sequences markedly impaired melanoma cell survival compared with individual therapies. These findings indicate that mechanisms beyond early ROS generation contribute to the enhanced response and support PDT combined with RT as a promising strategy to overcome melanoma resistance.
This work was supported by Comissão Nacional de Energia Nuclear (CNEN) and by the IAEA Marie Skłodowska-Curie Fellowship Programme at different stages of the research.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper